Acute miliary tuberculosis of multiple sites
ICD-10 A19.1 is a billable code used to indicate a diagnosis of acute miliary tuberculosis of multiple sites.
Acute miliary tuberculosis is a disseminated form of tuberculosis (TB) characterized by the presence of numerous small lesions (millet seed-sized) throughout the body, particularly in the lungs and other organs. This condition arises when Mycobacterium tuberculosis spreads through the bloodstream, leading to a systemic infection. Patients may present with nonspecific symptoms such as fever, night sweats, weight loss, and fatigue, alongside respiratory symptoms like cough and chest pain. Diagnosis typically involves a combination of clinical evaluation, imaging studies such as chest X-rays or CT scans, and microbiological tests including sputum smear and culture for Mycobacterium tuberculosis. Treatment requires a rigorous regimen of antitubercular medications, often including isoniazid, rifampicin, pyrazinamide, and ethambutol, administered over an extended period. Close monitoring for drug resistance and adverse effects is essential, as well as public health measures such as contact tracing and isolation of infectious patients to prevent further transmission. Miliary TB can lead to severe complications if not promptly treated, making early diagnosis and intervention critical.
Detailed clinical notes on symptoms, diagnostic tests, and treatment plans.
Patients presenting with systemic symptoms and confirmed TB diagnosis.
Need for thorough documentation of drug resistance testing and treatment adherence.
Pulmonary function tests, imaging results, and treatment response notes.
Patients with respiratory symptoms and confirmed miliary TB.
Documentation of lung involvement and any respiratory complications.
Used for screening in suspected TB cases.
Document the reason for testing and results.
Infectious disease specialists may require additional details on exposure history.
Common symptoms include fever, night sweats, weight loss, fatigue, cough, and chest pain. Symptoms can vary based on the organs affected.
Diagnosis typically involves clinical evaluation, imaging studies (like chest X-rays or CT scans), and microbiological tests such as sputum smear and culture.
Treatment usually involves a combination of antitubercular medications, including isoniazid, rifampicin, pyrazinamide, and ethambutol, for an extended period.
Public health measures include contact tracing, isolation of infectious patients, and monitoring for drug resistance.
